These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 918321)

  • 21. [In vitro effects of cefotetan on anaerobic bacteria of the genus Bacteroides fragilis group, in comparison with 8 antibiotics].
    Trevisan R; Proietti A; Pitzus E
    G Ital Chemioter; 1985; 32(2):367-70. PubMed ID: 3869115
    [No Abstract]   [Full Text] [Related]  

  • 22. [Susceptibility of the Bacteroides fragilis group to 10 antibiotics. Results of 4 laboratories in Austria].
    Mittermayer H; Rotter M; Riezinger F; Thiel W; Stanek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):500-11. PubMed ID: 3799095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early susceptibility test results with the Bacteroides fragilis group.
    Aldridge KE
    J Antimicrob Chemother; 1993 Dec; 32(6):910-2. PubMed ID: 8144437
    [No Abstract]   [Full Text] [Related]  

  • 24. Newer beta-lactam agents and the Bacteroides fragilis group.
    Cuchural GJ
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteroides fragilis. Its isolation and antibiotic sensitivity].
    Cancet B; Nadaud M
    Ann Biol Clin (Paris); 1976; 34(2):133-7. PubMed ID: 970703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bacteroides fragilis and its role in infections].
    Meisel H
    Pol Tyg Lek; 1978 Jan; 33(2):71-3. PubMed ID: 347417
    [No Abstract]   [Full Text] [Related]  

  • 28. Variation in susceptibility patterns of species within the Bacteroides fragilis group.
    Hansen SL
    Antimicrob Agents Chemother; 1980 Apr; 17(4):686-90. PubMed ID: 7396458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial resistance in Bacteroides.
    Wexler HM; Finegold SM
    J Antimicrob Chemother; 1987 Feb; 19(2):143-6. PubMed ID: 3553132
    [No Abstract]   [Full Text] [Related]  

  • 30. Susceptibility testing of anaerobes with Etest.
    Bolmström A
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S367-70. PubMed ID: 8324149
    [No Abstract]   [Full Text] [Related]  

  • 31. Multicenter in vitro study of the susceptibility of the Bacteroides fragilis group in Belgium.
    Glupczynski Y; Yourassowsky E
    Acta Clin Belg; 1986; 41(3):167-72. PubMed ID: 3766035
    [No Abstract]   [Full Text] [Related]  

  • 32. Anaerobic susceptibility tests. Evaluation of the stability of antimicrobials in Wilkens-Chalgren broth and the effect of media prereduction.
    Murray PR; Christman JL
    J Antibiot (Tokyo); 1978 Dec; 31(12):1296-8. PubMed ID: 738968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaerobic susceptibility tests: differences between disc diffusion, agar dilution and broth microdilution test results.
    Barry AL
    J Antimicrob Chemother; 1990 May; 25(5):875-7. PubMed ID: 2373671
    [No Abstract]   [Full Text] [Related]  

  • 34. Susceptibility of Bacteroides fragilis to spectinomycin.
    Phillips I; Warren C
    J Antimicrob Chemother; 1975 Mar; 1(1):91-5. PubMed ID: 240793
    [No Abstract]   [Full Text] [Related]  

  • 35. Trends in antimicrobial resistance of the Bacteroides fragilis group: a 20-year study at a medical center in Buenos Aires, Argentina.
    Bianchini H; Fernández Canigia LB; Bantar C; Smayevsky J
    Clin Infect Dis; 1997 Sep; 25 Suppl 2():S268-9. PubMed ID: 9310702
    [No Abstract]   [Full Text] [Related]  

  • 36. Susceptibility of bacteroides to noxythiolin.
    George RH; Healing DE
    Br Med J; 1977 Dec; 2(6100):1478-9. PubMed ID: 589283
    [No Abstract]   [Full Text] [Related]  

  • 37. Discrepant behaviour of clotrimazole against Bacteroides fragilis in liquid and solid media.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1977 Nov; 3(6):622-4. PubMed ID: 599124
    [No Abstract]   [Full Text] [Related]  

  • 38. Bacteroides fragilis and nitroimidazoles.
    Ferguson IR; Smith LL
    J Antimicrob Chemother; 1976 Jun; 2(2):220-1. PubMed ID: 956086
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Susceptibility of Bacteroides fragilis to spectinomycin.
    Okubadejo OA
    J Antimicrob Chemother; 1975 Sep; 1(3):347-8. PubMed ID: 126984
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Bacteroides fragilis and spectinomycin.
    Ferguson IR; Smith LL
    J Antimicrob Chemother; 1975 Jun; 1(2):245-6. PubMed ID: 126220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.